A significant shift in our drug policy has happened, as the regulators permit the availability of psilocybin mushrooms for therapeutic applications. Until now, these substances were strictly restricted, but a increasing body of studies suggests they could offer relief for mental health conditions like PTSD. This development represents a key step to